Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.2070
-0.0222 (-9.69%)
At close: Mar 16, 2026, 4:00 PM EDT
0.2370
+0.0300 (14.49%)
After-hours: Mar 16, 2026, 6:54 PM EDT
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $7.4 million as of March 16, 2026. Its market cap has decreased by -68.95% in one year.
Market Cap
7.40M
Enterprise Value
7.06M
1-Year Change
-68.95%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $7.40M, a decrease of -97.46%. That is a compound annual growth rate of -29.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 10.38M | -21.58% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenetic Biosciences | 7.78M |
| CollPlant Biotechnologies | 7.67M |
| Kiora Pharmaceuticals | 7.63M |
| Alaunos Therapeutics | 7.37M |
| Moolec Science | 7.33M |
| Cardio Diagnostics Holdings | 7.25M |
| PharmaCyte Biotech | 7.09M |
| Dogwood Therapeutics | 7.09M |